FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code”) 1. KEY INFORMATION ...

It forms the foundation for building a just, equitable, and progressive society by ensuring every child’s right to learn and grow. Without access to education, a child is deprived of their ...

Israel-based AION Labs and German independent research institute BioMed X announced its third global call for applications to form a new start ... to help ease the pharma industry's shared ...

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). If there are positions or ...

The TB Drug Accelerator, a partnership of seven pharmaceutical companies and four research institutions, has been launched with the aim to speed discovery of essential new treatments for ...

Investec is financial advisor to Aegros Bidco Limited (a newly incorporated company indirectly owned by DBAY Affiliates and the ERES IV Fund) ...